MAAT INDEX

CLAIM #22947 · EMR (EMR) · 2025Q4 earnings call · Nov 5, 2025 · due Sep 30, 2026

This headwind is projected to be $120 million for the full year.

Michael Baughman · CFO

PENDING
graded after results covering Sep 30, 2026 are reported

How to check this claim

Look at: Full-year revenue headwind from lower-value software contract renewals in Control Systems & Software segment, fiscal 2026

It came true if: Disclosed or implied headwind approximately $120 million (within +/-$15 million)

Where: Company management commentary on FY2026 earnings calls / 10-K segment disclosures

In context

llion. Turning to the first quarter. Sales growth is expected to be 4% with underlying sales growth of 2%. Adjusted segment EBITDA margin is guided to be approximately 27%, and we expect to deliver adjusted earnings per share of approximately $1.40 in the first quarter. Please turn to Slide 11 for additional details on 2026 guidance. I would like to take a few minutes to provide further granularity on sales growth and to explain some dynamics affecting margins and EPS growth rates. Our Test & Measurement segment is planned to have high single-digit growth in both the first half and full year, while the Control Systems & Software segment is expected to be down low single digits in the first half due to a $110 million headwind from a lower value of software contracts up for renewal in 2026. This headwind is projected to be $120 million for the full year. The underlying health of our Software businesses remains robust with ACV expected to grow 10% plus in 2026, but having fewer contracts up for renewal adversely affects GAAP revenues. This accounting dynamic does not affect cash flows and reverses through 2027 and 2028 when we expect to see tailwinds from renewals. The Intelligent Devices business group is projected to grow 3% in the first half and 4% for the full year with sustained strength in MRO across core verticals. Second half growth is supported by backlog phasing and the timing of project shipments. Overall, Emerson expects to grow approximately 2% in the first half and 4% for the full year. Excluding the impact of software contract renewals, Emerson's growth rate is approximately 4% in the first half, 6% for the second half and 5

Verify independently

SEC filings for EMR · Claim quote is verbatim from the 2025Q4 earnings call.